An update to " The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe"

Mark Jit; Marie Josée J. Mangen; Hugues Melliez; Yazdan Yazdanpanah; Joke Bilcke; Heini Salo; W. John Edmunds; Philippe Beutels

doi:10.1016/j.vaccine.2010.08.060

An update to " The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe"

Mark Jit, Marie Josée J. Mangen, Hugues Melliez, Yazdan Yazdanpanah, Joke Bilcke, Heini Salo, W. John Edmunds, Philippe Beutels

Global Public Health

Research output: Contribution to journal › Letter › peer-review

Abstract

A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.

Original language	English (US)
Pages (from-to)	7457-7459
Number of pages	3
Journal	Vaccine
Volume	28
Issue number	47
DOIs	https://doi.org/10.1016/j.vaccine.2010.08.060
State	Published - Nov 3 2010

Keywords

Cost-effectiveness
Rotavirus
Vaccination

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2010.08.060

Cite this

@article{bf0072eb7acd4dc6a337733edcb0f83c,

title = "An update to {"} The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe{"}",

abstract = "A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.",

keywords = "Cost-effectiveness, Rotavirus, Vaccination",

author = "Mark Jit and Mangen, {Marie Jos{\'e}e J.} and Hugues Melliez and Yazdan Yazdanpanah and Joke Bilcke and Heini Salo and Edmunds, {W. John} and Philippe Beutels",

year = "2010",

month = nov,

day = "3",

doi = "10.1016/j.vaccine.2010.08.060",

language = "English (US)",

volume = "28",

pages = "7457--7459",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "47",

}

TY - JOUR

T1 - An update to " The cost-effectiveness of rotavirus vaccination

T2 - Comparative analyses for five European countries and transferability in Europe"

AU - Jit, Mark

AU - Mangen, Marie Josée J.

AU - Melliez, Hugues

AU - Yazdanpanah, Yazdan

AU - Bilcke, Joke

AU - Salo, Heini

AU - Edmunds, W. John

AU - Beutels, Philippe

PY - 2010/11/3

Y1 - 2010/11/3

N2 - A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.

AB - A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices.

KW - Cost-effectiveness

KW - Rotavirus

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=77958192364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958192364&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.08.060

DO - 10.1016/j.vaccine.2010.08.060

M3 - Letter

C2 - 20846529

AN - SCOPUS:77958192364

SN - 0264-410X

VL - 28

SP - 7457

EP - 7459

JO - Vaccine

JF - Vaccine

IS - 47

ER -

An update to " The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe"

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this